What is PTC Therapeutics's R&D?

PTC Therapeutics (PTCT) reported R&D of $100.87M in Q1 2026.

How has PTC Therapeutics's R&D changed year-over-year?

PTC Therapeutics's R&D decreased by 7.4% year-over-year, from $108.97M to $100.87M.

What is the long-term trend for PTC Therapeutics's R&D?

Over 4 years (2021 to 2025), PTC Therapeutics's R&D has grown at a -4.2% compound annual growth rate (CAGR), from $540.68M to $455.25M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

PTC Therapeutics PTCT R&D

R&D at other companies

BioMarin PharmaceuticalsBMRN

$178.8M+12.6%

BridgeBio PharmaBBIO

$126.64M+13.6%

Arrowhead ResearchARWR

$173.25M+30.2%

United TherapeuticsUTHR

$138.2M-7.2%

BiogenBIIB

$539M+24.2%

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's R&D?: PTC Therapeutics (PTCT) reported R&D of $100.87M in Q1 2026.
How has PTC Therapeutics's R&D changed year-over-year?: PTC Therapeutics's R&D decreased by 7.4% year-over-year, from $108.97M to $100.87M.
What is the long-term trend for PTC Therapeutics's R&D?: Over 4 years (2021 to 2025), PTC Therapeutics's R&D has grown at a -4.2% compound annual growth rate (CAGR), from $540.68M to $455.25M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.